EpiCept Obtains New $10.6 Million Secured Debt Financing; Prepays Outstanding Convertible Notes
May 31, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Obtains New $10.6 Million Secured Debt Financing; Prepays
Outstanding Convertible Notes
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation...
EpiCept to Present at the 18th Annual Euro-Biotech Forum
May 19, 2011 17:02 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the 18th Annual Euro-Biotech Forum
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm:...
EpiCept Corporation Reports First Quarter 2011 Financial Results and Provides Business Update
May 10, 2011 00:02 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Reports First Quarter 2011 Financial Results and
Provides Business Update
Conference Call Begins at 9:00 A.M. Eastern Time Today
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept Files Protocol with FDA for Ceplene® Phase III Confirmatory Trial
May 09, 2011 18:05 ET
|
Immune Pharmaceuticals Inc
EpiCept Files Protocol with FDA for Ceplene® Phase III Confirmatory
Trial
SPECIAL PROTOCOL ASSESSMENT WILL FACILITATE NDA SUBMISSION
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept to Report First Quarter 2011 Operating and Financial Results on May 10, 2011
May 05, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept to Report First Quarter 2011 Operating and Financial Results on
May 10, 2011
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq...
Notice of the Annual Meeting of Stockholders of EpiCept Corporation
May 02, 2011 18:01 ET
|
Immune Pharmaceuticals Inc
Notice of the Annual Meeting of Stockholders of EpiCept Corporation
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
With this notice, stockholders of EpiCept...
EpiCept's Board of Directors Appoints New Independent Member
April 28, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept's Board of Directors Appoints New Independent Member
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm:...
EpiCept Receives Nasdaq Staff Determination Letter
April 08, 2011 17:00 ET
|
Immune Pharmaceuticals Inc
EpiCept Receives Nasdaq Staff Determination Letter
Company to Appeal for Additional Time to Regain Compliance
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory...
EpiCept to Raise $4.6 Million in Registered Direct Offering
March 29, 2011 00:16 ET
|
Immune Pharmaceuticals Inc
EpiCept to Raise $4.6 Million in Registered Direct Offering
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
EpiCept Corporation (Nasdaq and OMX Stockholm Exchange: EPCT)...
EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic Outlook 2011 Conference
March 28, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the Bio Windhover/Pharmaceutical Strategic Outlook
2011 Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation...